HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mengdan Wu Selected Research

Mengdan Wu Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 01/2019
2Neoplasm Metastasis (Metastasis)
01/2021 - 12/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Ovarian Neoplasms (Ovarian Cancer)
12/2020
1Breast Neoplasms (Breast Cancer)
08/2020
1Carcinoma (Carcinomatosis)
01/2019
1Colonic Neoplasms (Colon Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

2Immunoconjugates (Immunoconjugate)IBA
08/2020 - 01/2019
1pyrrolo(2,1-c)(1,4)benzodiazepineIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2021
1GSK 1363089IBA
01/2021
1AntigensIBA
12/2020
1Chimeric Antigen ReceptorsIBA
12/2020
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2020
1Interleukin-2 (IL2)IBA
12/2020
1Glycoproteins (Glycoprotein)IBA
12/2020
1CytokinesIBA
12/2020
1Therapeutic UsesIBA
08/2020
1cryptophycin 55IBA
08/2020
1Trastuzumab (Herceptin)FDA Link
08/2020
1ProdrugsIBA
08/2020
1Hydroxyl RadicalIBA
08/2020
1serum P-component (CIt)IBA
08/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019
1nilotinibFDA Link
01/2019
1Phosphotransferases (Kinase)IBA
01/2019

Therapy/Procedure

3Therapeutics
01/2021 - 08/2020
2Immunotherapy
01/2021 - 12/2020